Key terms
About ALDX
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ALDX news
Apr 30
3:31am ET
Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Dexcom (DXCM) and Aldeyra Therapeutics (ALDX)
Apr 25
7:13am ET
Aldeyra Therapeutics Unveils R&D Progress and Goals
Apr 08
3:18pm ET
Fly Insider: Xilio, Aerovate among weekâs notable insider trades
Apr 05
10:40am ET
Biotech Alert: Searches spiking for these stocks today
Apr 03
7:27am ET
Oppenheimer more bullish on Aldeyra, upgrades to Outperform
Apr 03
7:08am ET
Aldeyra upgraded to Outperform from Perform at Oppenheimer
Apr 02
6:20am ET
Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Carisma Therapeutics (CARM) and Panbela Therapeutics (OtherPBLA)
Mar 28
7:15am ET
Aldeyra in FDA clinical plan for NDA resubmission of reproxalap for DED
Mar 28
7:12am ET
Aldeyra Therapeutics Unveils Reproxalap Development Update
Mar 13
2:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 10
5:27pm ET
Strong Buy Rating for Aldeyra Therapeutics Backed by Reproxalap Developments and Strategic Partnerships
Mar 07
4:56pm ET
Aldeyra files $200M mixed securities shelf
Mar 04
10:50am ET
Biotech Alert: Searches spiking for these stocks today
Feb 13
4:13pm ET
Aldeyra CEO Speaks at Oppenheimer Healthcare Conference
Apr 15
4:45am ET
Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalf
Mar 29
10:40am ET
Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors
Mar 27
5:21pm ET
Notice to Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors
Mar 20
9:40am ET
Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)
ALDX Financials
Key terms
Ad Feedback
ALDX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ALDX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range